Assignee
ALS THERAPY DEV FOUNDATION INC
US·4 granted patents·24 citations·filing 2002–2003
Top patents by PatentIndex Score
4 records- 0182US7273888B2Use of difluoromethylornithine (DFMO) for the treatment of amyotrophic lateral sclerosisALS THERAPY DEV FOUNDATION INC·Filed 2002·Granted Sep 25, 2007·14 cites·8 claims
- 0274US7030126B2Use of polyamine analogs for amyotrophic lateral sclerosisALS THERAPY DEV FOUNDATION INC·Filed 2002·Granted Apr 18, 2006·6 cites·5 claims
- 0360US7902185B2Treatment of neurodegenerative diseases using proteasome modulatorsALS THERAPY DEV FOUNDATION INC·Filed 2003·Granted Mar 8, 2011·4 cites·12 claims
- 0453US7211602B2Treatment of neurodegenerative disorders through the modulation of the polyamine pathwayALS THERAPY DEV FOUNDATION INC·Filed 2002·Granted May 1, 2007·0 cites·4 claims
Join the waitlist — get patent alerts
Get an alert when ALS THERAPY DEV FOUNDATION INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →